Online FIrst Nr100

Psychiatr. Pol. ONLINE FIRST Nr 100
 
Published ahead of print 30 May 2018
 
 
Joanna Rymaszewska, Katarzyna Urbańska, Dorota Szcześniak, Tomasz Pawłowski,
Karolina Pieniawska-Śmiech, Izabela Kokot, Lilla Pawlik-Sobecka, Sylwia Płaczkowska,
Agnieszka Zabłocka, Bartłomiej Stańczykiewicz

FREE POLISH FULLTEXT: 

FREE ENGLISH FULLTEXT:
 
Summary
Objective: More effective, tolerable interventions for unipolar depression treatment are needed. Whole-body cryotherapy (WBC), which is a treatment using cryogenic temperature, is a novel therapeutic modality in neurology and rheumatology. The objective of this study was to determine the efficacy and safety of WBC as an add-on treatment for unipolar depression.
Methods: 30 adults diagnosed with unipolar depressive episode were recruited to an observational, prospective study. 21 participants (17 women, 81%), mean age 46.1 (±16.7), completed the whole study procedure. Hamilton Depression Rating Scale and the Beck Depression Inventory were used to assess the severity of depressive symptoms. Additionally quality of life and anhedonia were assessed with WHOQoL-BREF and SHAPS. Participants undertook 10,  2-minutes (-110 C till -135 C) WBC sessions on weekdays.
Results: Patients after WBC sessions showed significant improvement compared to their baseline scores taking into account depressive symptoms measured by HDRS (p<0.00001) in total scores between T1 (16.94±4.3) and T4 (4.50±4.2) and by BDI-II (T1: 13.48±4.6; T4: 6.14±6.7, p<0.03), lower anhedonia level on SHAPS (p=0.011) and higher quality of life between T1 and T4 in: physical health (p=0.024), psychological health (p=0.016) and environmental (p=0.003) domains. Pre/post comparison of self-report well-being measured by VAS scale showed a significant increase (p<0.00001). It was shown that WBC have no effect on cytokine, NO, hsCRP, ESR and TAS in blood (p>0.05).
Conclusions: In the pilot study, WBC was an effective, safe, and tolerable add-on intervention for this small unipolar depression sample. Further RCT trials should examine WBC efficacy in a larger group.

ISSN 0033-2674 (PRINT)

ISSN 2391-5854 (ONLINE)


Psychiatria Polska
is an Open Access journal:
Creative Commons: CC-BY
SHERPA RoMEO:
Blue


Czasopismo dofinansowane
ze środków DUN MNiSW


RODO - informacje (Pol.)
RODO - personal data (Eng.)



Inne strony PTP:
Other PTP websites:

www.psychiatria.org.pl
www.psychiatriapsychoterapia.pl

www.archivespp.pl
www.psychoterapiaptp.pl

Psychiatria Polska
INDEXED IN:
Thomson Reuters Master List
Science Citation Index Expanded
Journal Citation Reports
(Impact Factor 1,196)

Medline/Index Medicus
MNiSW (15 pkt)
Scopus/SCImago
EMBASE/Excerpta Medica
PsycINFO, EBSCO, DOAJ
Index Copernicus
Erih Plus, Cochrane Library
CrossRef/DOI

We recommend:

Pharmacological Reports



+48  518-330-994
kontakt z Biurem KRW PTP